申请人:Lui Weiguo
公开号:US20080076810A1
公开(公告)日:2008-03-27
Benzourea compounds of Formula I having aryl-(CH
2
)
x
-oxazolidinedione or aryl-(CH
2
)
x
-thiazolidinedione substituents on one of the N atoms of the benzourea ring, wherein x is 0 or 1, are PPAR gamma agonists or partial agonists and are useful in the treatment and control of type II diabetes, including hyperglycemia and other symptoms such as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity, that are often associated with type 2 diabetes.
具有在苯甲酰脲环的一个N原子上具有芳基-(CH2)x-噁唑啉二酮或芳基-(CH2)x-噻唑啉二酮取代基的公式I的苯甲酰脲化合物,其中x为0或1,是PPAR gamma激动剂或部分激动剂,并且在治疗和控制II型糖尿病,包括高血糖和其他症状,如血脂异常、高脂血症、高胆固醇血症、高三酰甘油血症和肥胖症方面非常有用,这些症状通常与2型糖尿病相关。